REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Dec 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-12-08

Reporting Person: Landry Robert E (EVP Finance CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-08	Common Stock	A	3971	$0.0	Acquired	29957	Direct
2021-12-09	Common Stock	M	4250	$399.66	Acquired	34207	Direct
2021-12-09	Common Stock	F	3469	$657.11	Disposed	30738	Direct
2021-12-10	Common Stock	S	2	$656.46	Disposed	30736	Direct
2021-12-10	Common Stock	S	50	$657.53	Disposed	30686	Direct
2021-12-10	Common Stock	S	11	$658.52	Disposed	30675	Direct
2021-12-10	Common Stock	S	4	$659.49	Disposed	30671	Direct
2021-12-10	Common Stock	S	25	$661.48	Disposed	30646	Direct
2021-12-10	Common Stock	S	123	$662.06	Disposed	30523	Direct
2021-12-10	Common Stock	S	19	$663.41	Disposed	30504	Direct
2021-12-10	Common Stock	S	15	$664.71	Disposed	30489	Direct
2021-12-10	Common Stock	S	18	$665.44	Disposed	30471	Direct
2021-12-10	Common Stock	S	68	$666.19	Disposed	30403	Direct
2021-12-10	Common Stock	S	7	$667.8	Disposed	30396	Direct
2021-12-10	Common Stock	S	178	$668.21	Disposed	30218	Direct
2021-12-10	Common Stock	S	130	$669.48	Disposed	30088	Direct
2021-12-10	Common Stock	S	58	$670.13	Disposed	30030	Direct
2021-12-10	Common Stock	S	14	$671.42	Disposed	30016	Direct
2021-12-10	Common Stock	S	59	$672.3	Disposed	29957	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-09	Non-Qualified Stock Option (right to buy)	$399.66	M	4250	Disposed	2024-12-16	Common Stock (4250)	Direct
2021-12-08	Non-Qualified Stock Option (right to buy)	$644.54	A	16958	Acquired	2031-12-08	Common Stock (16958)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	229	Indirect

Footnotes

F1: Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.

F2: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F3: Represents volume-weighted average price of sales of 50 shares of Company stock on December 10, 2021 at prices ranging from $657.19 to $657.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 11 shares of Company stock on December 10, 2021 at prices ranging from $658.10 to $658.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 4 shares of Company stock on December 10, 2021 at prices ranging from $659.36 to $659.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 25 shares of Company stock on December 10, 2021 at prices ranging from $661.26 to $661.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 123 shares of Company stock on December 10, 2021 at prices ranging from $662.06 to $662.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 19 shares of Company stock on December 10, 2021 at prices ranging from $663.16 to $663.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F9: Represents volume-weighted average price of sales of 18 shares of Company stock on December 10, 2021 at prices ranging from $665.20 to $665.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F10: Represents volume-weighted average price of sales of 7 shares of Company stock on December 10, 2021 at prices ranging from $667.39 to $667.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F11: Represents volume-weighted average price of sales of 178 shares of Company stock on December 10, 2021 at prices ranging from $668.10 to $668.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F12: Represents volume-weighted average price of sales of 130 shares of Company stock on December 10, 2021 at prices ranging from $669.43 to $669.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F13: Represents volume-weighted average price of sales of 58 shares of Company stock on December 10, 2021 at prices ranging from $670.12 to $670.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F14: Represents volume-weighted average price of sales of 14 shares of Company stock on December 10, 2021 at prices ranging from $671.42 to $671.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.

F15: The stock option award vests in four equal annual installments, commencing one year after the date of grant.